Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederesmo.org
ESMO News
Get the latest updates from ESMO News directly as they happen.
Follow now 79 followers
Latest posts
Last updated about 22 hours ago
Ensartinib Improves DFS Outcomes in Patients with ALK-positive, Completely Resected Stage II to IIIB NSCLC
about 22 hours ago
Findings from the ELEVATE study
EMA Recommends Extension of Therapeutic Indications for Epcoritamab
4 days ago
New indication concerns a combination with lenalidomide and rituximab for the treatment...
ESMO responds to European Commission consultation on high-risk AI rules to safeguard innovation and safety in cancer care
5 days ago
The European Society for Medical Oncology (ESMO) has submitted its response to...
Treatment with Encorafenib Plus Cetuximab Plus FOLFIRI Improves Outcomes in Patients with BRAF V600E-mutated mCRC
5 days ago
Findings from the BREAKWATER Cohort 3 study
FDA Approves Belzutifan with Pembrolizumab for Adjuvant Treatment of Renal Cell Carcinoma
6 days ago
Evidence for efficacy is based on the results from the LITESPARK-022 study
Adding Belzutifan to Pembrolizumab Prolongs DFS After Nephrectomy in Patients with ccRCC at Increased Risk for Recurrence
7 days ago
Findings from the LITESPARK-022 study
Aiming to Improve Cancer Prevention, ESMO Calls for Strong Policy Measures to Fight the Tobacco Epidemic in Feedback on the EU Tobacco Products and Advertising Legislation
8 days ago
Given that up to 40% of all cancers are preventable, robust tobacco...
Temporary Interruption of Endocrine Therapy for Pregnancy, Including Use of Fertility Preservation, Does Not Increase Risk of Breast Cancer Events in Women with HR-positive Breast Cancer
8 days ago
Updated findings from the POSITIVE study
EMA Recommends Extension of Therapeutic Indications for Pembrolizumab
11 days ago
New indications concern treatment of adult patients with resectable muscle invasive bladder...
CD19-Directed CAR T-Cell Therapy Leads to Exceptionally Long Remissions in Some Patients with Relapsed or Refractory B-Cell non-Hodgkin Lymphomas
12 days ago
Findings from 10-year follow-up of a phase II study
The European Parliament’s Reports Include Several ESMO Asks and Materially Strengthen the European Commission Proposals Under the ‘Health Package’
13 days ago
Proposed changes to the EU in vitro diagnostic medical devices (IVDR) legislation...
ESMO Welcomes the WHO Global Status Report on Cancer with Key Recommendations for Equitable Cancer Care
13 days ago
ESMO hails the publication of the WHO Global Status Report on Cancer...